{'fraction_non_alphanumeric': 0.012853470437017995, 'fraction_numerical': 0.0, 'mean_word_length': 5.491666666666666, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Impact of Data Management on Clinical Research in Taiwan

The way in which clinical data management is organized and conducted is crucial to new drug approval. The lack of regional expertise and capability in clinical data management in Taiwan is one of the main reasons that most clinical research processes cannot be independently completed there. Recently, more attention has been paid to the clinical data management process in Taiwan. This paper provides an overview of the clinical research environment in Taiwan, clinical data management activities that impact clinical research, training, data collection, and implications. Companies with clinical data management capability will enjoy a competitive advantage leading to faster approval times for new therapeutic agents.